Common use of Target Exclusivity Clause in Contracts

Target Exclusivity. During the Term, but subject to Section 13.3(a)(ii) (Effect of Termination), Benitec shall not conduct, itself or through an Affiliate or Third Party, and shall not enable a Third Party to conduct, any pre-clinical or clinical development, manufacture, promotion, or commercialization of any compound, construct, composition or biological entity, regardless of modality directed to (i) any Collaboration Target for which Axovant is then developing a Collaboration Compound, or (ii) PABPN1.

Appears in 2 contracts

Sources: License and Collaboration Agreement (Axovant Sciences Ltd.), License and Collaboration Agreement (Benitec Biopharma LTD/ADR)